[ad_1]
Ricardo Dearatanha | Los Angeles Times | Getty Images
A research badociate performs a buffer exchange for protein formulation at AMGEN, a drug research and development laboratory.
Amgen shares fell 3% after the company posted weak forecasts for 2019 that overshadowed earnings higher than expected in the fourth quarter on Tuesday.
Source link
